Myeloma Patients in Phase 1 Trial Show High Response Rates with REGN5458 Treatment
Treatment with Regeneron Pharmaceuticals‘…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreTreatment with Regeneron Pharmaceuticals‘…
A single infusion of Celularity‘s PNK-007 — an…
Analysis Group is collaborating with China’s Institute…
Myeloma Research News brought you daily…
For people with multiple myeloma who don’t respond…
The Committee for Medicinal Products for Human Use (CHMP) has…